2017-2022 United States Onychomycosis (Tinea Unguium) Drug Market Report (Status and Outlook)

  • ID:PD019788
  • September 2017
  • LPI (LP Information)
                          

The Onychomycosis (Tinea Unguium) Drug market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.

In United States market, the top players include

  •     Pfizer
  •     Yangtze River
  •     Torrent Pharma
  •     J&J
  •     Chengdu Brilliant
  •     Novartis
  •     Qilu Pharmaceutical
  •     Hubei Hengan
  •     Xiuzheng Pharmaceutical
  •     Valeant Pharma
  •     TARO
  •     Perrigo
  •     Galderma
  •     Zhejiang Deyer
  •     Moberg

This report with sales, revenue and market share for each type, split by product types/category, covering
  •     Oral medication
  •     External medicine

This report focuses on sales, market share and growth rate of Onychomycosis (Tinea Unguium) Drug in each application, split by applications/end use industries, covers
  •     The Middle-aged
  •     Children
  •     The Aged

Table of Contents
 
2017-2022 United States Onychomycosis (Tinea Unguium) Drug Market Report (Status and Outlook)
 
1 Onychomycosis (Tinea Unguium) Drug Market Overview
1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Onychomycosis (Tinea Unguium) Drug Market Segment by Types
1.2.1 United States Onychomycosis (Tinea Unguium) Drug Sales Present Situation and Outlook by Types (2012-2022)
1.2.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Types in 2016
1.2.3 Oral medication
External medicine
1.3 United States Onychomycosis (Tinea Unguium) Drug Market Segment by Applications/End Use Industries
1.3.1 United States Onychomycosis (Tinea Unguium) Drug Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
1.3.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Applications/End Industrials in 2016
1.3.3 The Middle-aged
1.3.4 Children
The Aged
1.4 United States Onychomycosis (Tinea Unguium) Drug Overview and Market Size (Value) (2012-2022)
1.4.1 United States Market Onychomycosis (Tinea Unguium) Drug Overview
1.4.2 United States Onychomycosis (Tinea Unguium) Drug Market Size (Value and Volume) Status and Forecast (2012-2022)
2 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue (Value) and Market Share by Players/Manufacturers
2.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share (2012-2017) by Vendors/Manufacturers
2.2 United States Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Vendors (2012-2017)
2.3 United States Onychomycosis (Tinea Unguium) Drug Average Price by Vendors in 2016
2.4 United States Onychomycosis (Tinea Unguium) Drug Manufacturing Base Distribution, Sales Area, Product Types by Vendors
2.5 Onychomycosis (Tinea Unguium) Drug Market Competitive Situation and Trends
2.5.1 Onychomycosis (Tinea Unguium) Drug Market Concentration Rate
2.5.2 Onychomycosis (Tinea Unguium) Drug Market Share of Top 3 and Top 5 Vendors
2.5.3 Mergers & Acquisitions, Expansion
3 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue (Value) by Type and Application (2012-2017)
3.1 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Market Share and Price by Type (2012-2017)
3.1.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2012-2017)
3.1.2 United States Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2012-2017)
3.1.3 United States Onychomycosis (Tinea Unguium) Drug Price by Type (2012-2017)
3.2 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2012-2017)
3.3 United States Market Onychomycosis (Tinea Unguium) Drug Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
4 United States Onychomycosis (Tinea Unguium) Drug Vendors/Manufacturers Profiles and Sales Data
4.1 Pfizer
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.2 Yangtze River
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.3 Torrent Pharma
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.4 J&J
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 J&J Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.5 Chengdu Brilliant
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.6 Novartis
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.7 Qilu Pharmaceutical
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.7.2.1 Type 1
4.7.2.2 Type 2
4.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.8 Hubei Hengan
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.8.2.1 Type 1
4.8.2.2 Type 2
4.8.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.9 Xiuzheng Pharmaceutical
4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.9.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
9.9.2.1 Type 1
9.9.2.2 Type 2
4.9.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.9.4 Main Business/Business Overview
4.10 Valeant Pharma
4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.10.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.10.2.1 Type 1
4.10.2.2 Type 2
4.10.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.10.4 Main Business/Business Overview
4.11 TARO
4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.11.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.11.2.1 Type 1
4.11.2.2 Type 2
4.11.3 TARO Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.11.4 Main Business/Business Overview
4.12 Perrigo
4.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.12.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.12.2.1 Type 1
4.12.2.2 Type 2
4.12.3 Perrigo Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.12.4 Main Business/Business Overview
4.13 Galderma
4.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.13.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.13.2.1 Type 1
4.13.2.2 Type 2
4.13.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.13.4 Main Business/Business Overview
4.14 Zhejiang Deyer
4.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.14.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.14.2.1 Type 1
4.14.2.2 Type 2
4.14.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.14.4 Main Business/Business Overview
4.15 Moberg
4.15.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.15.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
4.15.2.1 Type 1
4.15.2.2 Type 2
4.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
4.15.4 Main Business/Business Overview
5 Production Cost Analysis of Onychomycosis (Tinea Unguium) Drug
5.1 Main Raw Materials of Onychomycosis (Tinea Unguium) Drug
5.1.1 List of Onychomycosis (Tinea Unguium) Drug Main Raw Materials
5.1.2 Onychomycosis (Tinea Unguium) Drug Main Raw Materials Price Analysis
5.1.3 Onychomycosis (Tinea Unguium) Drug Raw Materials Major Suppliers
5.1.4 Onychomycosis (Tinea Unguium) Drug Main Raw Materials Market Concentration Rate
5.2 Production Cost Structure of Onychomycosis (Tinea Unguium) Drug
5.2.1 Raw Materials
5.2.2 Labor Cost
5.2.3 Production Expenses
5.3 Onychomycosis (Tinea Unguium) Drug Manufacturing Process/Method
6 Value Chain, Purchasing Strategy and Downstream Buyers
6.1 Onychomycosis (Tinea Unguium) Drug Value Chain Analysis
6.2 Upstream Raw Materials Purchasing
6.3 Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Vendors in 2016
6.4 Downstream Buyers
7 Marketing Strategy Analysis, Distributors/Traders
7.1 Sales Channel
7.1.1 Direct Sales
7.1.2 Indirect Sales
7.1.3 Sales Channel Development Trend
7.2 Product Market Positioning
7.2.1 Pricing Strategy
7.2.2 Brand Strategy
7.2.3 Target Client
7.3 Onychomycosis (Tinea Unguium) Drug Distributors/Traders List in United States
8 Market Influences Factors Analysis
8.1 Changes from the Related Industries
8.2 Substitutes Threat
8.3 Customer Preference Change
8.4 Economic/Political Environmental Change
8.5 Upstream and Downstream Fluctuation
9 United States Onychomycosis (Tinea Unguium) Drug Market Forecast (2017-2022)
9.1 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Price Forecast (2017-2022)
9.1.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2017-2022)
9.1.2 United States Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate Forecast (2017-2022)
9.1.3 United States Onychomycosis (Tinea Unguium) Drug Price Trend Forecast (2017-2022)
9.2 United States Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2017-2022)
9.3 United States Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2017-2022)
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Insights, Forecast to 2025

Tigecycline Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..